Infection of immunosuppressed patients.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000917:Antibody Formation; D001424:Bacterial Infections / Q000150:complications; D003586:Cytomegalovirus Infections / Q000150:complications; D006098:Granulocytes; D006509:Hepatitis B / Q000150:complications; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D017053:Infection Control; D007239:Infections / Q000150:complications* / Q000175:diagnosis; D009181:Mycoses / Q000150:complications; D009503:Neutropenia / Q000628:therapy; D011528:Protozoan Infections / Q000150:complications; D014777:Virus Diseases / Q000150:complications
D000900:Anti-Bacterial Agents